Lukas Mödl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lukas Mödl has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Hendrik Schmidt
Julius Wolff Institute, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
5 shared publications - Bernhard Ulrich Hoehl
Center for Musculoskeletal Surgery, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10178 Berlin, Germany
4 shared publications - Matthias Pumberger
Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany
4 shared publications - Lukas Schönnagel
Center for Musculoskeletal Surgery, Charité - University Medicine Berlin, Berlin, Germany
3 shared publications - Ulrike Grittner
Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
3 shared publications Anett Reißhauer
2 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Evaluation of an Integrated Multidisciplinary Care Model for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a Prospective, Open-label, Non-randomized Controlled Intervention Study
BackgroundMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disabling condition with limited treatment options and inadequate healthcare structures worldwide. We assessed the effectiveness of an integrated care model specifically adapted for ME/CFS.MethodsIn this prospective, open-label, non-randomized controlled intervention study conducted at Charité Fatigue Center we enrolled patients with ME/CFS between 2022 and 2023. Participants in the intervention group received multidisciplinary specialist assessment, comprehensive clinical management, and tailored inpatient rehabilitation, while the control group received a single outpatient consultation and a medical report for their primary physician. Primary outcome was change in physical functioning, measured using the SF-36 physical functioning subscale, at 12 months. Secondary outcomes included disability, symptom severity, quality of life, handgrip strength, and steps per day.Results89 intervention and 93 control participants were included in the per-protocol analysis. At 12 months, no statistically significant difference in SF-36 physical functioning scores was observed between groups. Secondary outcomes also showed no substantial between-group differences. Inpatient rehabilitation was completed by all participants who initiated it. Most participants reported that rehabilitation was helpful for learning disease management strategies, and for coping better with daily life. Post-rehabilitation Bell Disability Scale scores decreased in 42/94 (45%) and increased in only 13/94 (14%) patients.ConclusionsThe integrated multidisciplinary care model was feasible and associated with high retention but did not improve physical functioning or key secondary outcomes at 12 months. Current rehabilitative and management strategies may be insufficient to alter disease trajectory, underscoring the need for more effective, disease-modifying therapeutic interventions.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEvaluation of an Integrated Multidisciplinary Care Model for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a Prospective, Open-label, Non-randomized Controlled Intervention Study
BackgroundMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disabling condition with limited treatment options and inadequate healthcare structures worldwide. We assessed the effectiveness of an integrated care model specifically adapted for ME/CFS.MethodsIn this prospective, open-label, non-randomized controlled intervention study conducted at Charité Fatigue Center we enrolled patients with ME/CFS between 2022 and 2023. Participants in the intervention group received multidisciplinary specialist assessment, comprehensive clinical management, and tailored inpatient rehabilitation, while the control group received a single outpatient consultation and a medical report for their primary physician. Primary outcome was change in physical functioning, measured using the SF-36 physical functioning subscale, at 12 months. Secondary outcomes included disability, symptom severity, quality of life, handgrip strength, and steps per day.Results89 intervention and 93 control participants were included in the per-protocol analysis. At 12 months, no statistically significant difference in SF-36 physical functioning scores was observed between groups. Secondary outcomes also showed no substantial between-group differences. Inpatient rehabilitation was completed by all participants who initiated it. Most participants reported that rehabilitation was helpful for learning disease management strategies, and for coping better with daily life. Post-rehabilitation Bell Disability Scale scores decreased in 42/94 (45%) and increased in only 13/94 (14%) patients.ConclusionsThe integrated multidisciplinary care model was feasible and associated with high retention but did not improve physical functioning or key secondary outcomes at 12 months. Current rehabilitative and management strategies may be insufficient to alter disease trajectory, underscoring the need for more effective, disease-modifying therapeutic interventions.
- 4 November 2025
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 484 (1) , 201-203
Reply to the Letter to the Editor: Modic Changes Are Associated With Increased Pain Intensity, Greater Disability, And Reduced Quality Of Life In Low Back Pain: A Cross-Sectional Study
- 4 November 2025
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 484 (1) , 201-203
Reply to the Letter to the Editor: Modic Changes Are Associated With Increased Pain Intensity, Greater Disability, And Reduced Quality Of Life In Low Back Pain: A Cross-Sectional Study
- Open Access
Prediction of Occult Cervical Lymph Node Metastasis in Bone-Invasive pT4a cN0 Oral Squamous Cell Carcinoma in Relation to Tumor Size: A Retrospective Observational Cohort Study
Objective: The T classification of oral squamous cell carcinoma (OSCC) is linear according to the tumor size, excluding T4a by its criteria of invasion into adjacent structures, such as cortical bone. This may lead to the upstaging of otherwise small tumors. The objective was to analyze patients with OSCC and negative nodal staging to assess the impact of T-staging with tumor size on the incidence of occult cervical lymph node metastasis (CLNM) and regional neck failure. Methods: This retrospective cohort study included patients with OSCC and clinically negative necks (cN0), treated surgically between 2010 and 2024. All T4a OSCC classified due to bone invasion were additionally reclassified into T1–T3 based on size and depth of invasion according to the current staging manual. The primary endpoint of this study was the association between OSCC stratified by T-stage and tumor size as well as the presence of occult CLNM. Results: A total of 642 patients were included, with an overall occult CLNM rate of 20.2%. Bone invasion in T1-sized tumors was significantly associated with occult CLNM (OR 6.38, 95% CI: 1.48–27.42), whereas no such association was observed in T2 or T3 tumors (OR 0.80, 95% CI: 0.37–1.73; and OR 0.77, 95% CI: 0.37–1.62, respectively). Additionally, in T1–T2 tumors, bone invasion did not correlate with worse survival outcomes. Conclusions: Bone invasion was not significantly associated with occult CLNM in T2-3 sized OSCC, suggesting that the prognostic relevance is size-dependent. These findings question the uniform upstaging to T4a and support a more differentiated approach, potentially enabling neck management de-escalation in selected early-stage cases.
Open AccessPrediction of Occult Cervical Lymph Node Metastasis in Bone-Invasive pT4a cN0 Oral Squamous Cell Carcinoma in Relation to Tumor Size: A Retrospective Observational Cohort Study
Objective: The T classification of oral squamous cell carcinoma (OSCC) is linear according to the tumor size, excluding T4a by its criteria of invasion into adjacent structures, such as cortical bone. This may lead to the upstaging of otherwise small tumors. The objective was to analyze patients with OSCC and negative nodal staging to assess the impact of T-staging with tumor size on the incidence of occult cervical lymph node metastasis (CLNM) and regional neck failure. Methods: This retrospective cohort study included patients with OSCC and clinically negative necks (cN0), treated surgically between 2010 and 2024. All T4a OSCC classified due to bone invasion were additionally reclassified into T1–T3 based on size and depth of invasion according to the current staging manual. The primary endpoint of this study was the association between OSCC stratified by T-stage and tumor size as well as the presence of occult CLNM. Results: A total of 642 patients were included, with an overall occult CLNM rate of 20.2%. Bone invasion in T1-sized tumors was significantly associated with occult CLNM (OR 6.38, 95% CI: 1.48–27.42), whereas no such association was observed in T2 or T3 tumors (OR 0.80, 95% CI: 0.37–1.73; and OR 0.77, 95% CI: 0.37–1.62, respectively). Additionally, in T1–T2 tumors, bone invasion did not correlate with worse survival outcomes. Conclusions: Bone invasion was not significantly associated with occult CLNM in T2-3 sized OSCC, suggesting that the prognostic relevance is size-dependent. These findings question the uniform upstaging to T4a and support a more differentiated approach, potentially enabling neck management de-escalation in selected early-stage cases.
- Open Access
- 14 August 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (8) , 878
Comprehensive Analysis of Chronic Low Back Pain: Morphological and Functional Impairments, Physical Activity Patterns, and Epidemiology in a German Population-Based Cross-Sectional Study
Low back pain (LBP) is the leading cause of disability worldwide. While studies often focus on the relationship between magnetic resonance imaging (MRI) findings and symptoms or the link between pain and disability, comprehensive assessments that incorporate both structural and functional impairments are lacking. This study prospectively includes standardized questionnaires, medical histories, clinical exams, and lumbar–pelvic MRI. Participants were grouped by pain status, physical activity, structural impairments (e.g., Pfirrmann, Krämer, Fujiwara, Meyerding), and posture/mobility deviations. Data were analyzed using the Kruskal–Wallis test. Of the 1262 participants, 392 (31%) reported chronic low back pain (cLBP), 226 (18%) had intermittent low back pain (iLBP), and 335 (27%) were pain-free. Significant differences were observed in high physical activity levels based on WHO criteria (cLBP: 79%, iLBP: 78%, no-BP(2): 86%, p = 0.020, η2 = 0.008). Morphological impairments were more prevalent in cLBP (75%) and iLBP (76%) compared to no-BP(2) (55%) (p = 0.000, η2 = 0.043). Functional impairments showed similar patterns (cLBP: 42%, iLBP: 51%, no-BP(2): 38%, p = 0.014, η2 = 0.010). Participants with functional impairments tended to be younger. Consequently, the current classification system for diagnostics needs to incorporate alternative categories to more accurately differentiate types of back pain, which could enhance therapeutic outcomes.
- 14 August 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (8) , 878
Open AccessComprehensive Analysis of Chronic Low Back Pain: Morphological and Functional Impairments, Physical Activity Patterns, and Epidemiology in a German Population-Based Cross-Sectional Study
Low back pain (LBP) is the leading cause of disability worldwide. While studies often focus on the relationship between magnetic resonance imaging (MRI) findings and symptoms or the link between pain and disability, comprehensive assessments that incorporate both structural and functional impairments are lacking. This study prospectively includes standardized questionnaires, medical histories, clinical exams, and lumbar–pelvic MRI. Participants were grouped by pain status, physical activity, structural impairments (e.g., Pfirrmann, Krämer, Fujiwara, Meyerding), and posture/mobility deviations. Data were analyzed using the Kruskal–Wallis test. Of the 1262 participants, 392 (31%) reported chronic low back pain (cLBP), 226 (18%) had intermittent low back pain (iLBP), and 335 (27%) were pain-free. Significant differences were observed in high physical activity levels based on WHO criteria (cLBP: 79%, iLBP: 78%, no-BP(2): 86%, p = 0.020, η2 = 0.008). Morphological impairments were more prevalent in cLBP (75%) and iLBP (76%) compared to no-BP(2) (55%) (p = 0.000, η2 = 0.043). Functional impairments showed similar patterns (cLBP: 42%, iLBP: 51%, no-BP(2): 38%, p = 0.014, η2 = 0.010). Participants with functional impairments tended to be younger. Consequently, the current classification system for diagnostics needs to incorporate alternative categories to more accurately differentiate types of back pain, which could enhance therapeutic outcomes.
- 5 June 2025
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 483 (12) , 2353-2363
Modic Changes Are Associated With Increased Pain Intensity, Greater Disability, and Reduced Quality of Life in Low Back Pain: A Cross-Sectional Study
Background: Low back pain (LBP) is a common health problem and a major contributor to disability. Modic changes, or vertebral marrow changes visible on MRI, are frequently observed in individuals with LBP. However, there is inconsistent evidence assessing the relationship between Modic changes and LBP, pain-related disability, and quality of life. Questions/purposes: (1) Are Modic change parameters, including their type, number, and extent, positively associated with the characteristics of LBP, particularly when classified into intermittent LBP and chronic LBP? (2) Are Modic change parameters associated with participant-reported longer duration and higher intensity of LBP? (3) Are Modic change parameters associated with worsened pain-related disability and poorer quality of life? Methods: This study was a Phase III, single-center, cross-sectional analysis drawing its data from the ongoing Berlin Back Study (research unit FOR5177). A total of 1218 participants who met the inclusion and exclusion criteria were recruited between January 2022 and January 2024. Of these, 18% (217 of 1218) were excluded because of the lack of results from orthopaedic clinical examination and MRI evaluation. After clinical examination and completion of questionnaires, another 24% (289 of 1218) were excluded because of pain in other locations or pain experienced in the past, leaving 58% (712 of 1218) of participants in our study. The individuals included in this study had a mean age of 42 ± 11 years, with 57% women and 43% men. Data on demographic characteristics, LBP features, pain-related disability, and quality of life were collected using structured questionnaires and clinical evaluations. Three independent evaluators, blinded to the participants’ demographic information and health status, assessed the Modic change parameters, referring to signal alterations in the vertebrae’s endplate. The relationship between Modic change parameters and individual health status was assessed using multiple regression analysis after adjustment for age, gender, BMI, smoking and alcohol consumption, disc herniation, facet joint degeneration, and spinal instability. Results: Among the common Modic change parameters, when Type I Modic changes were observed, we found higher odds of chronic LBP (OR 7.3 [95% confidence interval (CI) 3.1 to 17.0]; p < 0.001) and intermittent LBP (OR 4.9 [95% CI 1.7 to 14.0]; p = 0.003) after adjusting for potential confounders. However, when greater depth and area of Modic changes were observed, we found higher odds of chronic LBP (OR 3.1 [95% CI 1.3 to 7.3]; p = 0.01 and OR 1.3 [95% CI 1.0 to 1.7]; p = 0.03, respectively) but not of intermittent LBP (OR 1.2 [95% CI 0.4 to 4.1]; p = 0.72 and OR 1.0 [95% CI 0.7 to 1.3]; p = 0.86, respectively). In the chronic LBP subgroup, we found that Type I Modic changes were associated with slightly higher maximum pain intensity (β 1.1 [95% CI 0.4 to 1.7]; p = 0.001), and multiple Modic changes were associated with modestly longer duration of chronic LBP (β 5.1 [95% CI 1.2 to 9.0]; p = 0.01). Increased Modic change depth and area were associated with slightly higher pain intensity in the chronic LBP group but not in the intermittent LBP group. In addition, Type II and single Modic changes were associated with slightly worsened pain-related disability (β 1.1 [95% CI 0.1 to 2.0]; p = 0.03 and β 1.5 [95% CI 0.6 to 2.4]; p = 0.001, respectively). The presence of Modic changes was also associated with slightly poorer quality of life, particularly in terms of physical health. Conclusion: Modic changes were found to be associated with higher odds of LBP, greater pain intensity, worsened pain-related disability, and reduced quality of life. The Type I and larger Modic changes were associated with slightly higher intensity of chronic LBP and slightly reduced physical function. Our study associated Modic changes with these findings, but it was not designed to demonstrate a causal relationship. Future studies will need to explore the causal relationship between Modic changes and health conditions, as well as whether targeting Modic changes could offer a potential approach to alleviating LBP. Level of Evidence: Level III, prognostic study.
- 5 June 2025
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 483 (12) , 2353-2363
Modic Changes Are Associated With Increased Pain Intensity, Greater Disability, and Reduced Quality of Life in Low Back Pain: A Cross-Sectional Study
Background: Low back pain (LBP) is a common health problem and a major contributor to disability. Modic changes, or vertebral marrow changes visible on MRI, are frequently observed in individuals with LBP. However, there is inconsistent evidence assessing the relationship between Modic changes and LBP, pain-related disability, and quality of life. Questions/purposes: (1) Are Modic change parameters, including their type, number, and extent, positively associated with the characteristics of LBP, particularly when classified into intermittent LBP and chronic LBP? (2) Are Modic change parameters associated with participant-reported longer duration and higher intensity of LBP? (3) Are Modic change parameters associated with worsened pain-related disability and poorer quality of life? Methods: This study was a Phase III, single-center, cross-sectional analysis drawing its data from the ongoing Berlin Back Study (research unit FOR5177). A total of 1218 participants who met the inclusion and exclusion criteria were recruited between January 2022 and January 2024. Of these, 18% (217 of 1218) were excluded because of the lack of results from orthopaedic clinical examination and MRI evaluation. After clinical examination and completion of questionnaires, another 24% (289 of 1218) were excluded because of pain in other locations or pain experienced in the past, leaving 58% (712 of 1218) of participants in our study. The individuals included in this study had a mean age of 42 ± 11 years, with 57% women and 43% men. Data on demographic characteristics, LBP features, pain-related disability, and quality of life were collected using structured questionnaires and clinical evaluations. Three independent evaluators, blinded to the participants’ demographic information and health status, assessed the Modic change parameters, referring to signal alterations in the vertebrae’s endplate. The relationship between Modic change parameters and individual health status was assessed using multiple regression analysis after adjustment for age, gender, BMI, smoking and alcohol consumption, disc herniation, facet joint degeneration, and spinal instability. Results: Among the common Modic change parameters, when Type I Modic changes were observed, we found higher odds of chronic LBP (OR 7.3 [95% confidence interval (CI) 3.1 to 17.0]; p < 0.001) and intermittent LBP (OR 4.9 [95% CI 1.7 to 14.0]; p = 0.003) after adjusting for potential confounders. However, when greater depth and area of Modic changes were observed, we found higher odds of chronic LBP (OR 3.1 [95% CI 1.3 to 7.3]; p = 0.01 and OR 1.3 [95% CI 1.0 to 1.7]; p = 0.03, respectively) but not of intermittent LBP (OR 1.2 [95% CI 0.4 to 4.1]; p = 0.72 and OR 1.0 [95% CI 0.7 to 1.3]; p = 0.86, respectively). In the chronic LBP subgroup, we found that Type I Modic changes were associated with slightly higher maximum pain intensity (β 1.1 [95% CI 0.4 to 1.7]; p = 0.001), and multiple Modic changes were associated with modestly longer duration of chronic LBP (β 5.1 [95% CI 1.2 to 9.0]; p = 0.01). Increased Modic change depth and area were associated with slightly higher pain intensity in the chronic LBP group but not in the intermittent LBP group. In addition, Type II and single Modic changes were associated with slightly worsened pain-related disability (β 1.1 [95% CI 0.1 to 2.0]; p = 0.03 and β 1.5 [95% CI 0.6 to 2.4]; p = 0.001, respectively). The presence of Modic changes was also associated with slightly poorer quality of life, particularly in terms of physical health. Conclusion: Modic changes were found to be associated with higher odds of LBP, greater pain intensity, worsened pain-related disability, and reduced quality of life. The Type I and larger Modic changes were associated with slightly higher intensity of chronic LBP and slightly reduced physical function. Our study associated Modic changes with these findings, but it was not designed to demonstrate a causal relationship. Future studies will need to explore the causal relationship between Modic changes and health conditions, as well as whether targeting Modic changes could offer a potential approach to alleviating LBP. Level of Evidence: Level III, prognostic study.
- 16 April 2025
- Published by Springer Nature in European Spine Journal
- Vol. 34 (6) , 2387-2396
The role of spinal and hip mobility in disability among patients with chronic low back pain
Background Chronic low back pain (cLBP) imposes substantial functional limitations and contributes significantly to healthcare costs worldwide. Identifying factors associated with disability is crucial for developing targeted strategies. Thus, this study aims to determine the relationship between mobility impairments and disability in individuals with cLBP. Methods In this cross-sectional study, a adults aged 18–64 were enrolled from the general population, stratified by pain status: no LBP, intermediate LBP, and chronic LBP. Disability and pain intensity were evaluated using the Roland-Morris Disability Scale and the von Korff Chronic Pain Grade Questionnaire. Multivariable regression models examined the associations between the mobility parameters, disability, and pain intensity, adjusting for age, sex, body mass index (BMI), physical activity level, work status and smoking. Results 1,239 participants (55.8% female) were included. Disability was significantly associated with spinal and hip mobility impairments in the cLBP group but not in those with intermediate LBP or no LBP. In specific, lower lumbar sagittal (β: -0.04, 95% CI: -0.07– -0.01, p = 0.009) and coronal mobility (β: -0.06, 95%CI: -0.08 - -0.03, p < 0.001), as well as hip rotational (β: -0.06, 95%CI: -0.09 - -0.03, p < 0.001) and coronal mobility (β: -0.05, 95%CI: -0.07 - -0.02, p < 0.001), were associated with higher disability scores. In contrast, most mobility parameters showed no significant association with pain. Conclusions This study demonstrates that both spinal and hip mobility impairments are independently associated with disability in individuals with cLBP. Notably, hip mobility was equally relevant as spinal mobility, underscoring the need for comprehensive mobility assessments in clinical practice.
- 16 April 2025
- Published by Springer Nature in European Spine Journal
- Vol. 34 (6) , 2387-2396
The role of spinal and hip mobility in disability among patients with chronic low back pain
Background Chronic low back pain (cLBP) imposes substantial functional limitations and contributes significantly to healthcare costs worldwide. Identifying factors associated with disability is crucial for developing targeted strategies. Thus, this study aims to determine the relationship between mobility impairments and disability in individuals with cLBP. Methods In this cross-sectional study, a adults aged 18–64 were enrolled from the general population, stratified by pain status: no LBP, intermediate LBP, and chronic LBP. Disability and pain intensity were evaluated using the Roland-Morris Disability Scale and the von Korff Chronic Pain Grade Questionnaire. Multivariable regression models examined the associations between the mobility parameters, disability, and pain intensity, adjusting for age, sex, body mass index (BMI), physical activity level, work status and smoking. Results 1,239 participants (55.8% female) were included. Disability was significantly associated with spinal and hip mobility impairments in the cLBP group but not in those with intermediate LBP or no LBP. In specific, lower lumbar sagittal (β: -0.04, 95% CI: -0.07– -0.01, p = 0.009) and coronal mobility (β: -0.06, 95%CI: -0.08 - -0.03, p < 0.001), as well as hip rotational (β: -0.06, 95%CI: -0.09 - -0.03, p < 0.001) and coronal mobility (β: -0.05, 95%CI: -0.07 - -0.02, p < 0.001), were associated with higher disability scores. In contrast, most mobility parameters showed no significant association with pain. Conclusions This study demonstrates that both spinal and hip mobility impairments are independently associated with disability in individuals with cLBP. Notably, hip mobility was equally relevant as spinal mobility, underscoring the need for comprehensive mobility assessments in clinical practice.
- Open Access
- 21 March 2025
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 10 (2) , e1249
Fear-avoidance beliefs are associated with changes of back shape and function
Introduction: Psychosocial function in people with chronic low back pain (cLBP) is often impaired, indicating poor well-being. Fear-avoidance beliefs (FAB) are common concomitants of cLBP. Fear-avoidance beliefs are gaining attention as a potential prognostic factor for chronification and resulting disability in cLBP. This article aims to examine the associations of back function with FAB. Methods: This study presents data from a cohort study (DRKS00027907). In the present cross-sectional analyses, we included 914 participants (480 nonchronic LBP [ncLBP], 227 cLBP, 207 asymptomatic). Fear-avoidance beliefs were assessed using the fear-avoidance belief questionnaire (FABQ). The association between the FAB and clinical measures (Ott and Schober test, the sit-to-stand test [STS], and the finger-floor distance [FFD]) were analyzed. Back shape and function were also measured using a noninvasive device. The association between FABQ scores and clinical measures was assessed using age, body mass index, sex, and pain intensity–adjusted multiple linear regression models. Results: Associations between FAB and both clinical (Ott, Schober, STS, FFD) and noninvasive device measures were small. All relevant clinical measures were attenuated in individuals with elevated FAB. Discussion: We were able to demonstrate the association of both back shape and function in both clinical tests and noninvasive device measurements with self-reported fear-avoidance beliefs. However, the effect sizes were small. This may be attributed to the different assessment methods (objective vs self-report), resulting in reduced common method variance. In addition to the FAB, there may be other factors (eg, altered neuronal pathways; actual avoidance behavior such as reduced physical activity) that contribute to functional impairment.
- 21 March 2025
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 10 (2) , e1249
Open AccessFear-avoidance beliefs are associated with changes of back shape and function
Introduction: Psychosocial function in people with chronic low back pain (cLBP) is often impaired, indicating poor well-being. Fear-avoidance beliefs (FAB) are common concomitants of cLBP. Fear-avoidance beliefs are gaining attention as a potential prognostic factor for chronification and resulting disability in cLBP. This article aims to examine the associations of back function with FAB. Methods: This study presents data from a cohort study (DRKS00027907). In the present cross-sectional analyses, we included 914 participants (480 nonchronic LBP [ncLBP], 227 cLBP, 207 asymptomatic). Fear-avoidance beliefs were assessed using the fear-avoidance belief questionnaire (FABQ). The association between the FAB and clinical measures (Ott and Schober test, the sit-to-stand test [STS], and the finger-floor distance [FFD]) were analyzed. Back shape and function were also measured using a noninvasive device. The association between FABQ scores and clinical measures was assessed using age, body mass index, sex, and pain intensity–adjusted multiple linear regression models. Results: Associations between FAB and both clinical (Ott, Schober, STS, FFD) and noninvasive device measures were small. All relevant clinical measures were attenuated in individuals with elevated FAB. Discussion: We were able to demonstrate the association of both back shape and function in both clinical tests and noninvasive device measurements with self-reported fear-avoidance beliefs. However, the effect sizes were small. This may be attributed to the different assessment methods (objective vs self-report), resulting in reduced common method variance. In addition to the FAB, there may be other factors (eg, altered neuronal pathways; actual avoidance behavior such as reduced physical activity) that contribute to functional impairment.
- Open Access
- 21 October 2024
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 34 (5) , 1236-1244
Noninvasive bracing of acromioclavicular joint dislocations is not superior to early functional rehabilitation and not inferior to surgical stabilization in Rockwood type III and V injuries
- 21 October 2024
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 34 (5) , 1236-1244
Open AccessNoninvasive bracing of acromioclavicular joint dislocations is not superior to early functional rehabilitation and not inferior to surgical stabilization in Rockwood type III and V injuries
- Open Access
- 14 November 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (22) , 7089
Follow-Up of Men Who Have Undergone Focal Therapy for Prostate Cancer with HIFU—A Real-World Experience
Purpose: To determine oncological and functional outcomes and side effects after focal therapy of prostate cancer (PCa) with high-intensity focused ultrasound (HIFU). Methods: This retrospective single-center study included 57 consecutive patients with localised PCa. Aged 18–80 with ≤2 suspicious lesions on mpMRI (PIRADS ≥ 3), PSA of ≤15 ng/mL, and an ISUP GG of ≤2. HIFU was performed between November 2014 and September 2018. All men had an MRI/US fusion-guided targeted biopsy (TB) combined with a TRUS-guided 10-core systematic biopsy (SB) prior to focal therapy. HIFU treatment was performed as focal, partial, or hemiablative, depending on the prior histopathology. Follow-up included Questionnaires (IIEF-5, ICIQ, and IPSS), prostate-specific antigen (PSA) measurement, follow-up mpMRI, and follow-up biopsies. Results: The median age of the cohort was 72 years (IQR 64–76), and the median PSA value before HIFU was 7.3 ng/mL (IQR 5.75–10.39 ng/mL). The median follow-up was 27.5 (IQR 23–41) months. At the time of the follow-up, the median PSA value was 2.5 ng/mL (IQR 0.94–4.96 ng/mL), which shows a significant decrease (p < 0.001). In 17 (29.8%) men, mpMRI revealed a suspicious lesion, and 19 (33.3%) men had a positive biopsy result. Only IIEF values significantly decreased from 16 (IQR 10.75–20.25) to 11.5 (IQR 4.5–17) (p < 0.001). The rate of post-HIFU complications was low, at 19.3% (11 patients). The limitation of this study is the lack of long-term follow-up. Conclusions: HIFU as a therapy option for nonmetastatic, significant prostate cancer is effective in the short term for carefully selected patients and shows a low risk of adverse events and side effects.
- 14 November 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (22) , 7089
Open AccessFollow-Up of Men Who Have Undergone Focal Therapy for Prostate Cancer with HIFU—A Real-World Experience
Purpose: To determine oncological and functional outcomes and side effects after focal therapy of prostate cancer (PCa) with high-intensity focused ultrasound (HIFU). Methods: This retrospective single-center study included 57 consecutive patients with localised PCa. Aged 18–80 with ≤2 suspicious lesions on mpMRI (PIRADS ≥ 3), PSA of ≤15 ng/mL, and an ISUP GG of ≤2. HIFU was performed between November 2014 and September 2018. All men had an MRI/US fusion-guided targeted biopsy (TB) combined with a TRUS-guided 10-core systematic biopsy (SB) prior to focal therapy. HIFU treatment was performed as focal, partial, or hemiablative, depending on the prior histopathology. Follow-up included Questionnaires (IIEF-5, ICIQ, and IPSS), prostate-specific antigen (PSA) measurement, follow-up mpMRI, and follow-up biopsies. Results: The median age of the cohort was 72 years (IQR 64–76), and the median PSA value before HIFU was 7.3 ng/mL (IQR 5.75–10.39 ng/mL). The median follow-up was 27.5 (IQR 23–41) months. At the time of the follow-up, the median PSA value was 2.5 ng/mL (IQR 0.94–4.96 ng/mL), which shows a significant decrease (p < 0.001). In 17 (29.8%) men, mpMRI revealed a suspicious lesion, and 19 (33.3%) men had a positive biopsy result. Only IIEF values significantly decreased from 16 (IQR 10.75–20.25) to 11.5 (IQR 4.5–17) (p < 0.001). The rate of post-HIFU complications was low, at 19.3% (11 patients). The limitation of this study is the lack of long-term follow-up. Conclusions: HIFU as a therapy option for nonmetastatic, significant prostate cancer is effective in the short term for carefully selected patients and shows a low risk of adverse events and side effects.